ScottK.HeysellMD
Infectious Disease • Charlottesville, VAThomas H. Hunter Assoc. Professor of Medicine, Infectious Diseases and International Health; Director, Center for Global Health Equity, University of Virginia
Dr. Heysell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1300 Jefferson Park Ave
Fl 5
Charlottesville, VA 22903Phone+1 434-243-9064Fax+1 434-924-0075
Education & Training
University of Virginia Medical CenterFellowship, Infectious Disease, 2009 - 2012
Yale-New Haven Medical CenterResidency, Internal Medicine, 2004 - 2007
Oregon Health and Science University School of MedicineClass of 2004
Certifications & Licensure
VA State Medical License 2009 - 2026
CT State Medical License 2007 - 2009- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100) Start of enrollment: 2016 Apr 28
- Improving HIV/Tuberculosis Outcomes in Irkutsk Start of enrollment: 2018 Apr 15
Publications & Presentations
PubMed
- 1 citationsPopulation Pharmacokinetics of Levofloxacin and Moxifloxacin, and the Probability of Target Attainment in Ethiopian Patients with Multidrug-Resistant Tuberculosis.Temesgen Sidamo, Prakruti S Rao, Eleni Aklillu, Workineh Shibeshi, Yumi Park
Infection and Drug Resistance. 2022-01-01 - 17 citationsCycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis.Wael A. Alghamdi, Abdullah Alsultan, Mohammad H. Al-Shaer, Guohua An, Shahriar Ahmed
Antimicrobial Agents and Chemotherapy. 2019-04-25 - 34 citationsClinical standards for the dosing and management of TB drugs.J W C Alffenaar, S L Stocker, L Davies Forsman, A Garcia-Prats, S K Heysell
The International Journal of Tuberculosis and Lung Disease. 2022-06-01
Journal Articles
- Oxford University Press Has Registered This DOI Pre-PublicationScott K Heysell, Tawanda Gumbo, Eric R Houpt, Devyani Deshpande, Oxford University Press
- Oxford University Press Has Registered This DOI Pre-PublicationDevyani Deshpande, Scott K Heysell, Tawanda Gumbo, Oxford University Press
- Oxford University Press Has Registered This DOI Pre-PublicationScott K Heysell, Devyani Deshpande, Tawanda Gumbo, Oxford University Press
Other
- Clinical manifestations, diagnosis, and treatment of extensively drug-resistant tuberculosisHeysell SK, Friedland G
http://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-extensively-drug
UpToDate, Wolters Kluwer Health - 2012-11-19 - Epidemiology of extensively drug-resistant tuberculosisHeysell SK, Friedland G
http://www.uptodate.com/contents/epidemiology-of-extensively-drug-resistant-tuberculosis
UpToDate, Wolters Kluwer Health - 2013-01-17
Press Mentions
UVA Doctors Decry Aggressive Billing Practices by Their Own HospitalNovember 25th, 2019
UVA Health Working on COVID-19 Convalescent Plasma StudyAugust 26th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
